A Long Term-Extension Study To Evaluate The Safety Of FILGOTINIB In Subjects With Ulcerative Colitis
Principal Investigator(s)
Email for information
Funded by
Geneva
Research Start Date
Status
Active
This is a long-term extension study to evaluate the safety of filgotinib administered to subjects with Ulcerative Colitis (UC).
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.